心脑舒通及其单体成分对小鼠脑微血管内皮细胞缺氧复氧炎症损伤的影响

2018-09-13 09:59:46柴丽娟王少峡徐杨杨马萌萌王乔悦胡利民
中国老年学杂志 2018年17期

袁 庆 柴丽娟 王少峡 郭 虹 赵 莼 徐杨杨 马萌萌 王乔悦 胡利民

(天津中医药大学 天津市中药药理学重点实验室 省部共建方剂学教育部重点实验室,天津 300193)

Theanti-inflammatoryeffectofXinnaoshutonginhypoxiaandreoxygenationmousebrainmicrovascularendothelialcells

YUANQing,CHAILi-Juan,WANGShao-Xia,etal.

TianjinKeyLaboratoryofChineseMedicinePharmacology,KeyLaboratoryofPharmacologyofTraditionalChineseMedicalFormulaeMinistryofEducation,TianjinUniversityofTraditionalChineseMedicine,Tianjin300193,China

【Abstract】ObjectiveTo investigate the effect of Xinnaoshutong and its monomer component on the inflammatory cytokines TNF-α, IL-6, IL-1β in cerebral ischemia and reperfusion mouse brain microvascular endothelial cells line bEnd.3.MethodsIschemia-reperfusion inflammation injury bEnd.3 cells model was established, the effect of different concentrations Xinnaoshutong (0.1,1.0,10.0,50.0 μg/ml) or the monomer component(10μmol/ml) on cells vitality of bEnd.3 was detected. Inflammation-related factor TNF-α, IL-6, IL-1βlevel were measured by ELISA.ResultsXinnaoshutong significantly inhibited bEnd.3 cell cytoplasmic synthesis of TNF-α, while the supernatants of IL-6 secretion was inhibited but there was no statistical difference. The cytoplasmic synthesis or supernatants of IL-1β expression in bEnd.3 cells was not obvious.ConclusionsXinnaoshutong plays a therapeutic role in inflammatory injury of cerebral ischemia by inhibiting the synthesis inflammatory cytokines of TNF-α.

【Keywords】 Xinnaoshutong; Cerebral ischemia and reperfusion; Inflammatory cytokines; TNF-α; IL-6

脑缺血后的强烈炎症反应是造成脑组织继发性损伤的因素之一,在此炎症反应的过程中,有多种因素相互作用,共同引起了再灌注损伤,并且以其预后差,死亡率高而日益引起人们的关注〔1〕。 心脑舒通胶囊是由中药蒺藜属植物蒺藜干燥的地上全草提取物而制成的胶囊剂,以蒺藜总皂甙为其主要成分,具有活血化瘀、祛痰化湿、补益肝肾等功效〔2~4〕。现代药理学研究表明,其具有改善微循环,选择性增加脑缺血部位的供血及提高抗氧自由基等作用〔5〕。但其在脑缺血再灌注炎症损伤中发挥作用的研究较少。本实验旨在考察心脑舒通及其单体成分对缺氧复氧合并肿瘤坏死因子(TNF)-α刺激损伤后bEnd.3(小鼠脑微血管内皮细胞)炎症相关因子TNF-α、白细胞介素(IL)-6、IL-1β释放的影响,初步探讨心脑舒通抗脑缺血再灌注炎症损伤的机制。

1 材料与方法

1.1材料 bEnd.3细胞株(ATCC,美国),DMEM培养基(Corning,美国),FBS(BI,美国),心脑舒通(吉林敖东股份有限公司,中国),化合物5:(26-O-β-D-吡喃葡萄糖基-(25R)-5α-呋甾-20(22)-烯-3β,26-二醇-3-O-{β-D-吡喃木糖基-(1→2)-〔β-D-吡喃木糖基-(1→3)〕-β-D-吡喃葡萄糖基-(1→4)-〔α-L-吡喃鼠李糖基-(1→2)〕-β-D-吡喃半乳糖苷})、原薯蓣皂苷(由天津中医药大学中医药研究院张鹏老师提供),无糖KRP(250 ml含NaCl 2.25 g/KCl 0.105 g/NaH2PO4·2H2O 0.032 5 g/ Na2HPO4·12H2O 0.180 25 g/MgSO40.067 5 g/CaCl20.081 g),高糖KRP(在无糖KRP基础上加葡萄糖1.125 g),CCK-8 (CCK-8,Dojindo,日本),TNF-α(R&D,美国),TNF-α试剂盒、IL-6试剂盒、IL-1β试剂盒(北京四正柏),37℃饱和湿度培养箱(Thermo,Forma3111型,美国),倒置相差显微镜(Nikon,TE200,日本),多功能读板机(TECAN公司,瑞士),低温高速离心机(Beckman,64R型,美国)。……

登录APP查看全文